WeightWatchers adds compounded version of Novo's obesity drug to weight-loss program
08/10/2024 14:17
Oct 8 (Reuters) - WeightWatchers WW.O said on Tuesday it is adding a compounded version of Novo Nordisk's NOVOb.CO obesity drug Wegovy to its weight-management programs. (Reporting by Puyaan Singh in Bengaluru; Editing by Shilpi Majumdar) ((Puyaan.Singh@thomsonreuters.com))
Recent news on WW International
See all newsBrief: WW International Emerges from Chapter 11 as Reorganization Plan Takes Effect
WeightWatchers to exit process to cut $1.15 billion debt next week
Brief: Weightwatchers’ Reorganization Plan Confirmed
Brief: Galloway Capital Partners Considering Legal Action Against Management And Board Of Weight Watchers International
WW International Inc reports results for the quarter ended March 31 - Earnings Summary